La tumeur à cellules géantes des os en 2022
- 3 May 2022
- journal article
- research article
- Published by Elsevier in Annales de Pathologie
- Vol. 42 (3) , 214-226
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- The H3F3 K36M mutant antibody is a sensitive and specific marker for the diagnosis of chondroblastomaHistopathology, 2016
- Mutation Analysis of H3F3A and H3F3B as a Diagnostic Tool for Giant Cell Tumor of Bone and ChondroblastomaAmerican Journal of Surgical Pathology, 2015
- A High-grade Sarcoma Arising in a Patient With Recurrent Benign Giant Cell Tumor of the Proximal Tibia While Receiving Treatment With DenosumabClinical Orthopaedics and Related Research, 2015
- Diagnostic value of H3F3A mutations in giant cell tumour of bone compared to osteoclast‐rich mimicsThe Journal of Pathology: Clinical Research, 2015
- A diagnosis of giant cell-rich tumour of bone is supported by p63 immunohistochemistry, when more than 50 % of cells is stainedVirchows Archiv, 2014
- Distinct H3F3A and H3F3B driver mutations define chondroblastoma and giant cell tumor of boneNature Genetics, 2013
- Properties of the Stromal Cell in Giant Cell Tumor of BoneClinical Orthopaedics and Related Research, 2007
- Osteoblast lineage properties in giant cell tumors of boneJournal of Orthopaedic Science, 2005
- Expression of preosteoblast markers and Cbfa-1 and Osterix gene transcripts in stromal tumour cells of giant cell tumour of boneBone, 2004
- Giant cell tumor in skeletally immature patients.Radiology, 1992